Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HCA HEALTHCARE, INC.

(HCA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

HCA Healthcare : Lifts Full-Year Outlook After Third Quarter Beats Street Expectations Amid Delta Variant Surge

10/22/2021 | 11:45am EST


ę MT Newswires 2021
All news about HCA HEALTHCARE, INC.
11/25HealthONE Announces HCA Healthcare Foundation's $50,000 Grant to the Emily Griffith Fou..
AQ
11/22HCA Healthcare Exceeds “Crush the Crisis” Record by Collecting 15,566 Pound..
BU
11/18HCA Healthcare Seeks M&A
CI
11/17HCA Healthcare Strengthens Partnership With March of Dimes to Help Give All Moms and Ba..
BU
11/17HCA Healthcare Strengthens Partnership With March of Dimes to Help Give All Moms and Ba..
CI
11/15Statewide Adoption of HCA Florida Healthcare Brand Begins with 11 Hospitals and Freesta..
BU
11/15INSIDER SELL : Hca Healthcare
MT
11/11HCA Healthcare, Inc. to Present at November Healthcare Conference
BU
11/11INSIDER SELL : HCA Healthcare
MT
11/09HCA Healthcare Announces $150,000 Donation to Local Veterans' Organizations
BU
More news
Analyst Recommendations on HCA HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2021 59 089 M - -
Net income 2021 6 591 M - -
Net Debt 2021 32 193 M - -
P/E ratio 2021 11,5x
Yield 2021 0,83%
Capitalization 71 846 M 71 846 M -
EV / Sales 2021 1,76x
EV / Sales 2022 1,69x
Nbr of Employees 235 000
Free-Float 77,1%
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 231,00 $
Average target price 279,57 $
Spread / Average Target 21,0%
EPS Revisions
Managers and Directors
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Thomas Fearn Frist Chairman
Jonathan B. Perlin Chief Medical Officer
P. Martin Paslick Chief Information Officer & Senior Vice President
Sector and Competitors